The global non small cell lung cancer market was valued at $15.3 billion in 2021, and is projected to reach $36.9 billion by 2031, growing at a CAGR of 9.3% from 2022 to 2031.
Report Code : A00544 | Pages : 262 | Category : Life Sciences
Castration-Resistant Prostate Cancer (CRPC) or Hormone Refractory Prostate Cancer (CRPC), a type of prostate cancer that typically recurs after administering androgen deprivation therapy (ADT), is gaining prominence in ...
Report Code : A00568 | Pages : 122 | Category : Life Sciences
The global vaccine adjuvants market was valued at $820.2 million in 2023, and is projected to reach $1,304.83 million by 2035, growing at a CAGR of 3.9% from 2024 to 2035.
Report Code : A01341 | Pages : 339 | Category : Life Sciences
The global pharmaceutical packaging market was valued at $111.7 billion in 2023, and is projected to reach $233.3 billion by 2035, growing at a CAGR of 6.3% from 2024 to 2035.
Report Code : A01501 | Pages : 275 | Category : Life Sciences
The global netupitant“palonosetron FDC market accounted for $257,162 million in 2015, and is estimated to reach $527,187 million by 2022, growing at a CAGR of 10.8% during the ...
Report Code : A01502 | Pages : 40 | Category : Life Sciences
LAMEA Oncology/Anti-cancer Drugs Market is expected to reach $17,072.2 million by 2021, registering a CAGR of 8.6% during the forecast period 2015 - 2021. Oncology drugs are used ...
Report Code : A00719 | Pages : 108 | Category : Life Sciences
The global empty capsules market size was valued at $2,382.7 million in 2020, and is projected to reach $5,230.4 million by 2030, registering a CAGR of 8.1% from ...
Report Code : A00835 | Pages : 290 | Category : Life Sciences
Pharmaceutical excipients are inert substances, other than the pharmacologically active drug, which are included in the manufacturing process or are present in the pharmaceutical product dosage form. Excipients ...
Report Code : A00899 | Pages : 116 | Category : Life Sciences
The global nuclear medicine market was valued at $5.5 billion in 2023, and is projected to reach $16.1 Billion by 2033, growing at a CAGR of 11.3% from 2024 to 2033
Report Code : A00971 | Pages : 260 | Category : Life Sciences
An influenza vaccine is a vaccine designed to protect against the influenza virus, commonly known as the flu, which comes in trivalent or quadrivalent types, used to treat seasonal and pandemic flu. It is based on egg-based and cell-based technology, used for adults and pediatric as well.
Report Code : A01118 | Pages : 217 | Category : Life Sciences
